vs
Arbutus Biopharma Corp（ABUS）与INTELLIGENT PROTECTION MANAGEMENT CORP.（IPM）财务数据对比。点击上方公司名可切换其他公司
Arbutus Biopharma Corp的季度营收约是INTELLIGENT PROTECTION MANAGEMENT CORP.的1.8倍（$10.7M vs $6.1M），INTELLIGENT PROTECTION MANAGEMENT CORP.同比增速更快（2091.6% vs 522.2%），过去两年INTELLIGENT PROTECTION MANAGEMENT CORP.的营收复合增速更高（54.7% vs -13.2%）
Arbutus生物制药是一家公开上市的加拿大生物制药企业，专长于脂质体药物递送与RNA干扰技术，目前主要开展针对乙型肝炎感染的治疗药物研发工作，在抗病毒新药研发领域拥有深厚的技术积累。
智能防护管理公司是一家总部位于英国格洛斯特郡的控股母公司，于2008年5月21日完成注册。公司为旗下四家子公司提供集团管理架构，其前身是专精于情报搜集、反间谍与反窃听检测业务的国际情报有限公司。
ABUS vs IPM — 直观对比
营收规模更大
ABUS
是对方的1.8倍
$6.1M
营收增速更快
IPM
高出1569.4%
522.2%
两年增速更快
IPM
近两年复合增速
-13.2%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.7M | $6.1M |
| 净利润 | $2.5M | — |
| 毛利率 | — | 53.1% |
| 营业利润率 | 13.9% | -13.4% |
| 净利率 | 23.5% | — |
| 营收同比 | 522.2% | 2091.6% |
| 净利润同比 | 112.7% | — |
| 每股收益（稀释后） | $0.01 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABUSIPM
| Q4 25 | — | $6.1M | ||
| Q3 25 | — | $6.2M | ||
| Q2 25 | $10.7M | $5.7M | ||
| Q1 25 | — | $5.5M | ||
| Q4 23 | $2.1M | $-7.3M | ||
| Q3 23 | $4.7M | $2.8M | ||
| Q2 23 | $4.7M | $3.0M | ||
| Q1 23 | $6.7M | $2.6M |
净利润ABUSIPM
| Q4 25 | — | — | ||
| Q3 25 | — | $-1.1M | ||
| Q2 25 | $2.5M | $-1.1M | ||
| Q1 25 | — | $808.5K | ||
| Q4 23 | — | — | ||
| Q3 23 | $-20.1M | $-181.6K | ||
| Q2 23 | $-17.1M | $135.6K | ||
| Q1 23 | $-16.3M | $-738.3K |
毛利率ABUSIPM
| Q4 25 | — | 53.1% | ||
| Q3 25 | — | 50.7% | ||
| Q2 25 | — | 50.1% | ||
| Q1 25 | — | 55.3% | ||
| Q4 23 | — | — | ||
| Q3 23 | — | 70.1% | ||
| Q2 23 | — | 73.8% | ||
| Q1 23 | — | 68.7% |
营业利润率ABUSIPM
| Q4 25 | — | -13.4% | ||
| Q3 25 | — | -23.0% | ||
| Q2 25 | 13.9% | -19.7% | ||
| Q1 25 | — | -24.2% | ||
| Q4 23 | -967.2% | — | ||
| Q3 23 | -462.8% | -14.1% | ||
| Q2 23 | -395.3% | -9.4% | ||
| Q1 23 | -260.4% | -35.5% |
净利率ABUSIPM
| Q4 25 | — | — | ||
| Q3 25 | — | -17.4% | ||
| Q2 25 | 23.5% | -18.3% | ||
| Q1 25 | — | 14.7% | ||
| Q4 23 | — | — | ||
| Q3 23 | -431.6% | -6.6% | ||
| Q2 23 | -367.5% | 4.6% | ||
| Q1 23 | -244.3% | -28.8% |
每股收益（稀释后）ABUSIPM
| Q4 25 | — | $-0.05 | ||
| Q3 25 | — | $-0.08 | ||
| Q2 25 | $0.01 | $-0.08 | ||
| Q1 25 | — | $0.06 | ||
| Q4 23 | $-0.12 | $-0.03 | ||
| Q3 23 | $-0.12 | $-0.02 | ||
| Q2 23 | $-0.10 | $0.01 | ||
| Q1 23 | $-0.10 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.4M | $5.6M |
| 总债务越低越好 | $0 | — |
| 股东权益账面价值 | $83.0M | $18.2M |
| 总资产 | $103.3M | $26.0M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资ABUSIPM
| Q4 25 | — | $5.6M | ||
| Q3 25 | — | $7.3M | ||
| Q2 25 | $37.4M | $7.3M | ||
| Q1 25 | — | $9.7M | ||
| Q4 23 | $126.0M | $13.6M | ||
| Q3 23 | $17.5M | $13.7M | ||
| Q2 23 | $27.2M | $13.7M | ||
| Q1 23 | $40.6M | $13.9M |
总债务ABUSIPM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | — | — | ||
| Q4 23 | $0 | — | ||
| Q3 23 | $0 | — | ||
| Q2 23 | $0 | — | ||
| Q1 23 | $0 | — |
股东权益ABUSIPM
| Q4 25 | — | $18.2M | ||
| Q3 25 | — | $18.8M | ||
| Q2 25 | $83.0M | $19.9M | ||
| Q1 25 | — | $21.1M | ||
| Q4 23 | $106.0M | $20.1M | ||
| Q3 23 | $119.3M | $20.4M | ||
| Q2 23 | $134.7M | $20.5M | ||
| Q1 23 | $143.9M | $20.3M |
总资产ABUSIPM
| Q4 25 | — | $26.0M | ||
| Q3 25 | — | $27.2M | ||
| Q2 25 | $103.3M | $29.8M | ||
| Q1 25 | — | $31.1M | ||
| Q4 23 | $144.4M | $23.9M | ||
| Q3 23 | $158.6M | $24.1M | ||
| Q2 23 | $176.8M | $24.4M | ||
| Q1 23 | $191.2M | $24.3M |
负债/权益比ABUSIPM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | — | — | ||
| Q4 23 | 0.00× | — | ||
| Q3 23 | 0.00× | — | ||
| Q2 23 | 0.00× | — | ||
| Q1 23 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.7M | $87.6K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | -6.24× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ABUSIPM
| Q4 25 | — | $87.6K | ||
| Q3 25 | — | $133.0K | ||
| Q2 25 | $-15.7M | $-888.7K | ||
| Q1 25 | — | $1.7M | ||
| Q4 23 | $-17.3M | $-99.0K | ||
| Q3 23 | $-21.8M | $16.1K | ||
| Q2 23 | $-19.6M | $-193.8K | ||
| Q1 23 | $-27.3M | $-803.0K |
自由现金流ABUSIPM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | $-21.8M | — | ||
| Q2 23 | $-20.4M | — | ||
| Q1 23 | $-27.4M | — |
自由现金流率ABUSIPM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | -468.4% | — | ||
| Q2 23 | -439.0% | — | ||
| Q1 23 | -410.0% | — |
资本支出强度ABUSIPM
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | — | — | ||
| Q4 23 | 0.0% | — | ||
| Q3 23 | 0.7% | — | ||
| Q2 23 | 18.5% | — | ||
| Q1 23 | 1.7% | — |
现金转化率ABUSIPM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | — | 2.16× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | -1.43× | ||
| Q1 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABUS
暂无分部数据
IPM
| Procurement Revenue | $5.4M | 88% |
| Other | $743.9K | 12% |
